Shares of BeiGene (NASDAQ: BGNE) were soaring 15.6% higher as of 3:38 p.m. EDT on Wednesday. The big jump came after the Chinese drugmaker filed a document to the U.S. Securities and Exchange Commission (SEC) related to the proposed public offering of its stock and listing on the Science and Technology Innovation Board (referred to as the "STAR Market") of the Shanghai Stock Exchange. Investors already knew that BeiGene planned the stock offering and listing on the STAR Market.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting